Literature DB >> 7895955

Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM.

A Schmitz1, M Vaeth, C E Mogensen.   

Abstract

We prospectively followed a cohort of 278 non-insulin-dependent (NIDDM) patients for a 6-year period, intending to estimate the rate of increase of albuminuria and to identify clinical variables that influence this increase. At baseline, normo-albuminuria (N) was seen in 74%, microalbuminuria (M) in 19% and 7% presented with proteinuria (P). A total of 80 patients died; they were older (p < 0.001) and had higher albumin excretion both at baseline and as an average during follow-up (p < 0.01). At baseline, patients with proteinuria had higher blood pressures (systolic and diastolic), whereas there was no difference between patients with normo-and microalbuminuria. Glycaemic control was increasingly poor throughout the three groups. At follow-up, an average relative rate of increase of albuminuria (slope) of 17% per year was seen both for patients with complete 6 years, follow-up (n - 135) and patients with at least 4 years follow-up (n = 178). Slope correlated significantly with systolic blood pressure (r = 0.26 and 0.29) in both groups, diastolic blood pressure only in the 4-year group (r = 0.22) and average albuminuria in both (r = 0.31 and 0.24). By multiple regression analyses systolic blood pressure and average albuminuria remained with significant influence on slope. Progression was defined as an increase in the category (e.g. normo- to microalbuminuria) as well as an increase of more than 20% in albumin excretion, and was seen in 46 patients with at least 4 years' follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7895955     DOI: 10.1007/bf00399799

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  50 in total

1.  Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment.

Authors:  A Schmitz; H H Hansen; T Christensen
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

2.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

Authors:  S M Haffner; M P Stern; H P Hazuda; B D Mitchell; J K Patterson
Journal:  JAMA       Date:  1990-06-06       Impact factor: 56.272

3.  Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

Authors:  A Schmitz; M Vaeth
Journal:  Diabet Med       Date:  1988-03       Impact factor: 4.359

4.  The consomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels.

Authors:  H Keen; C Chlouverakis; J Fuller; R J Jarrett
Journal:  Guys Hosp Rep       Date:  1969

5.  Systolic blood pressure relates to the rate of decline of glomerular filtration rate in type II diabetes.

Authors:  S Nielsen; A Schmitz; M Rehling; C E Mogensen
Journal:  Diabetes Care       Date:  1993-11       Impact factor: 19.112

Review 6.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

7.  A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM.

Authors:  A Neil; M Hawkins; M Potok; M Thorogood; D Cohen; J Mann
Journal:  Diabetes Care       Date:  1993-07       Impact factor: 19.112

8.  Eight to nine year mortality in known non-insulin dependent diabetics and controls.

Authors:  E M Damsgaard; A Frøland; O D Jørgensen; C E Mogensen
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

9.  Blood pressure by 24 h ambulatory recordings in type 2 (non-insulin dependent) diabetics. Relationship to urinary albumin excretion.

Authors:  A Schmitz; M M Pedersen; K W Hansen
Journal:  Diabete Metab       Date:  1991 Mar-Apr

10.  Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.

Authors:  Y Lacourcière; A Nadeau; L Poirier; G Tancrède
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

View more
  10 in total

Review 1.  Complications of diabetes: renal disease and promotion of self-management.

Authors:  A Melville; R Richardson; D Lister-Sharp; A McIntosh
Journal:  Qual Health Care       Date:  2000-12

2.  Renal cortical stiffness obtained by shear wave elastography imaging is increased in patients with type 2 diabetes mellitus without diabetic nephropathy.

Authors:  Ayse Selcan Koc; Hılmı Erdem Sumbul
Journal:  J Ultrasound       Date:  2018-07-26

Review 3.  Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

Authors:  Merlin C Thomas; Robert C Atkins
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Chemoprophylaxis of diabetic nephropathy in the elderly.

Authors:  E Jungmann
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

5.  The incidence of microalbuminuria and its associated risk factors in type 2 diabetic patients in isfahan, iran.

Authors:  Massoud Amini; Hassan Safaei; Ashraf Aminorroaya
Journal:  Rev Diabet Stud       Date:  2008-02-10

Review 6.  Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.

Authors:  Merlin C Thomas; Mark E Cooper; Paul Zimmet
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

7.  Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients.

Authors:  Hyun-Wook Chae; Jae-Il Shin; Ah-Reum Kwon; Ho-Seong Kim; Duk-Hee Kim
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

8.  Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.

Authors:  Janet Joy Kachuchuru Lutale; Hrafnkell Thordarson; Zulfiqarali Gulam Abbas; Kåre Vetvik
Journal:  BMC Nephrol       Date:  2007-01-15       Impact factor: 2.388

9.  Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus.

Authors:  Tsung-Hui Wu; Li-Hsin Chang; Chia-Huei Chu; Chii-Min Hwu; Harn-Shen Chen; Liang-Yu Lin
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

10.  Albuminuria and its correlates in an Iranian type 2 diabetic population.

Authors:  Manouchehr Nakhjavani; Alireza Esteghamati; Fatemeh Esfahanian; Naser Aghamohammadzadeh; Sepehr Hamidi; Alipasha Meysamie; Mehrshad Abbasi
Journal:  Lipids Health Dis       Date:  2008-08-10       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.